Winslow Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $26.7M | Sell |
29,022
-906
| -3% | -$919K | 5.19% | 3 |
|
|
2025
Q4 | $32.2M | Sell |
29,928
-1,688
| -5% | -$1.61M | 5.93% | 2 |
|
|
2025
Q3 | $24.1M | Sell |
31,616
-609
| -2% | -$453K | 4.53% | 5 |
|
|
2025
Q2 | $25.1M | Buy |
32,225
+147
| +0.5% | +$114K | 5.07% | 4 |
|
|
2025
Q1 | $26.5M | Sell |
32,078
-970
| -3% | -$807K | 5.84% | 2 |
|
|
2024
Q4 | $25.5M | Sell |
33,048
-995
| -3% | -$824K | 5.08% | 3 |
|
|
2024
Q3 | $30.2M | Sell |
34,043
-613
| -2% | -$551K | 5.58% | 3 |
|
|
2024
Q2 | $31.4M | Sell |
34,656
-1,802
| -5% | -$1.44M | 6.18% | 2 |
|
|
2024
Q1 | $28.4M | Sell |
36,458
-1,045
| -3% | -$744K | 5.34% | 3 |
|
|
2023
Q4 | $21.9M | Sell |
37,503
-402
| -1% | -$235K | 4.45% | 4 |
|
|
2023
Q3 | $20.4M | Sell |
37,905
-2,636
| -7% | -$1.36M | 4.72% | 4 |
|
|
2023
Q2 | $19M | Sell |
40,541
-594
| -1% | -$249K | 4.1% | 4 |
|
|
2023
Q1 | $14.1M | Sell |
41,135
-629
| -2% | -$212K | 3.3% | 7 |
|
|
2022
Q4 | $15.3M | Sell |
41,764
-2,714
| -6% | -$962K | 3.62% | 5 |
|
|
2022
Q3 | $14.4M | Sell |
44,478
-2,020
| -4% | -$640K | 3.75% | 3 |
|
|
2022
Q2 | $15.1M | Sell |
46,498
-56
| -0.1% | -$16.8K | 3.64% | 4 |
|
|
2022
Q1 | $13.3M | Sell |
46,554
-764
| -2% | -$197K | 2.63% | 10 |
|
|
2021
Q4 | $13.1M | Buy |
47,318
+111
| +0.2% | +$28.1K | 2.31% | 13 |
|
|
2021
Q3 | $10.9M | Sell |
47,207
-745
| -2% | -$184K | 2.11% | 18 |
|
|
2021
Q2 | $11M | Sell |
47,952
-1,265
| -3% | -$254K | 2.05% | 17 |
|
|
2021
Q1 | $9.2M | Sell |
49,217
-2,180
| -4% | -$426K | 1.86% | 22 |
|
|
2020
Q4 | $8.68M | Sell |
51,397
-567
| -1% | -$84.7K | 1.83% | 18 |
|
|
2020
Q3 | $7.69M | Sell |
51,964
-1,770
| -3% | -$274K | 1.96% | 18 |
|
|
2020
Q2 | $8.82M | Sell |
53,734
-868
| -2% | -$133K | 2.38% | 14 |
|
|
2020
Q1 | $7.57M | Sell |
54,602
-2,477
| -4% | -$340K | 2.49% | 16 |
|
|
2019
Q4 | $7.5M | Buy |
57,079
+1,611
| +3% | +$187K | 1.71% | 24 |
|
|
2019
Q3 | $6.2M | Sell |
55,468
-6,714
| -11% | -$747K | 1.55% | 27 |
|
|
2019
Q2 | $6.89M | Sell |
62,182
-4,250
| -6% | -$500K | 1.53% | 28 |
|
|
2019
Q1 | $8.62M | Sell |
66,432
-687
| -1% | -$83.5K | 1.81% | 22 |
|
|
2018
Q4 | $7.77M | Sell |
67,119
-213
| -0.3% | -$23.8K | 1.81% | 24 |
|
|
2018
Q3 | $7.22M | Sell |
67,332
-350
| -0.5% | -$35K | 1.32% | 36 |
|
|
2018
Q2 | $5.78M | Buy |
67,682
+270
| +0.4% | +$22.2K | 1.07% | 44 |
|
|
2018
Q1 | $5.22M | Buy |
67,412
+93
| +0.1% | +$7.49K | 1% | 47 |
|
|
2017
Q4 | $5.69M | Buy |
67,319
+355
| +0.5% | +$30.2K | 1.05% | 44 |
|
|
2017
Q3 | $5.73M | Sell |
66,964
-1,037
| -2% | -$85.1K | 1.11% | 46 |
|
|
2017
Q2 | $5.6M | Sell |
68,001
-830
| -1% | -$67.7K | 1.14% | 45 |
|
|
2017
Q1 | $5.79M | Sell |
68,831
-2,533
| -4% | -$203K | 1.19% | 42 |
|
|
2016
Q4 | $5.25M | Buy |
71,364
+2,495
| +4% | +$186K | 1.1% | 46 |
|
|
2016
Q3 | $5.53M | Sell |
68,869
-837
| -1% | -$67K | 1.22% | 40 |
|
|
2016
Q2 | $5.49M | Buy |
69,706
+830
| +1% | +$62.5K | 1.23% | 39 |
|
|
2016
Q1 | $4.96M | Sell |
68,876
-9,455
| -12% | -$715K | 1.11% | 45 |
|
|
2015
Q4 | $6.6M | Sell |
78,331
-355
| -0.5% | -$29.5K | 1.3% | 37 |
|
|
2015
Q3 | $6.58M | Buy |
78,686
+545
| +0.7% | +$46K | 1.3% | 43 |
|
|
2015
Q2 | $6.52M | Buy |
78,141
+431
| +0.6% | +$32.8K | 1.12% | 48 |
|
|
2015
Q1 | $5.65M | Sell |
77,710
-2,085
| -3% | -$148K | 0.95% | 51 |
|
|
2014
Q4 | $5.5M | Buy |
+79,795
| New | +$5.39M | 0.9% | 52 |
|
Other funds holding LLY
VCM
VPM
Winslow Asset Management's LLY Position: Q1 2026 in Review
Winslow Asset Management reduced its Eli Lilly (LLY) stake by 3% in Q1 2026, selling an estimated $919K and leaving 29,022 shares worth $26.7M. The position accounts for 5.19% of the portfolio, ranked #3.
Winslow Asset Management first reported a position in LLY in Q4 2014 and has held it in 46 quarters since. The position peaked at $32.2M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Winslow Asset Management held 29,022 shares of Eli Lilly worth $26.7M as of Q1 2026.
- Winslow Asset Management sold 906 Eli Lilly shares in Q1 2026, an estimated $919K.
- Eli Lilly made up 5.19% of Winslow Asset Management's portfolio in Q1 2026, its #3 holding.
- Winslow Asset Management first reported a position in Eli Lilly in Q4 2014 and has held it in 46 quarters since.
- Winslow Asset Management's Eli Lilly position peaked at $32.2M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Winslow Asset Management's 13F filing for Q1 2026, filed 5 May 2026.